Athenex, Inc. Announces Pricing of $110 Million Public Offering of Common Stock

NASDAQ Market News

NEXT STORY
Ascendis Pharma A/S Announces Presentations for TransCon™ PTH and Hypoparathyroidism at American Society for Bone and Mineral Research Annual Meeting
PREV STORY
InspireMD Announces Christina Brennan, M.D., MBA to Serve in Advisory Role for Pivotal Study of CGuard Carotid Stent System
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

New two-year data show Roche’s Evrysdi (risdiplam) continues to demonstrate improvement or maintenance of motor function in people aged 2-25 with Type 2 or Type 3 Spinal Muscular Atrophy (SMA)

author_avatar
NASDAQ Market News

Global Syringe & Needle Industry Assessment 2020-2025: COVID-19 Updated

author_avatar
NASDAQ Market News

Global Infection Control Market 2021-2026: Surge in Growth for E-Beam Sterilization and Re-Introduction of Ethylene Oxide Sterilization

author_avatar
NASDAQ Market News